Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis
Open Access
- 23 July 2020
- journal article
- editorial
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (4), 2002554
- https://doi.org/10.1183/13993003.02554-2020
Abstract
Cases of COVID-19 associated pulmonary aspergillosis (CAPA) are being increasingly reported and physicians treating patients with COVID-19-related lung disease need to actively consider these fungal co-infectionshttps://bit.ly/3feuGsQFunding Information
- Natural Environment Research Council (NE/P001165/1)
- Medical Research Council (MR/R015600/1)
- Canadian Institute for Advanced Research
This publication has 36 references indexed in Scilit:
- Comparison of 1,3-β- d -glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patientsJournal of Critical Care, 2016
- Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2016
- The emergence of the Middle East Respiratory Syndrome coronavirusPathogens and Disease, 2014
- Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective studyIntensive Care Medicine, 2012
- A Clinical Algorithm to Diagnose Invasive Pulmonary Aspergillosis in Critically Ill PatientsAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Beta- d -Glucan Detection as a Diagnostic Test for Invasive Aspergillosis in Immunocompromised Critically Ill Patients with Symptoms of Respiratory Infection: an Autopsy-Based StudyJournal of Clinical Microbiology, 2011
- Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?The Lancet Infectious Diseases, 2009
- Galactomannan in Bronchoalveolar Lavage FluidAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Pulmonary pathology of severe acute respiratory syndrome in TorontoLaboratory Investigation, 2005
- Fatal Aspergillosis in a Patient with SARS Who Was Treated with CorticosteroidsThe New England Journal of Medicine, 2003